Verana Health Raises $150M Series E Funding Round


Verana Health, a San Francisco-based digital health company, has raised $150m in Series E funding. The company delivers high-quality drug lifecycle information and insights for medical practice from a unique real-world data network.

Johnson & Johnson Innovation – JJDC, Inc. (JJDC, Inc.) and Novo Growth, Novo Holdings’ growth-stage investment arm, participated in the round with existing investors GV (formerly Google Ventures), Casdin Capital, Brook Byers, and Breyer Capital. Verana Health has added Jeffrey Low, MD, Principal of Novo Growth and a JJDC representative to its Board of Directors.

The company plans to use the funds for its life sciences product strategy and service strategy throughout the drug lifecycle, further increase its value proposition to healthcare providers who participate in its real-world network of data, and expand its data footprint via strategic partnerships and medical society.

Sujay Jadhav is the CEO of Verana Health. The company’s mission is to deliver quality information from a real-world network and provide insights into medical practice practices. Verana Health has been entrusted with data management by 70 electronic health record system providers and more than 20,000 healthcare providers. VeraQ(TM) is the healthcare data engine for Verana Health. It secures a data integrity feedback loop that powers nearly half-billion point-of-care medical encounters. The company uses advanced analytics to create fit-for-purpose quality data sets. Qdata(TM) helps life science collaborators generate real-world evidence and advance business insights. It also accelerates medical innovations that improve quality of care and life quality.

Verana Health, the American Academy of Ophthalmology and American Urological Association’s exclusive data partner, collaborates with multinational pharmaceutical and biopharmaceutical corporations as well as emerging biotechnology companies.

Get latest news from African Startup ecosystem

Latest stories

You might also like...